| Nesrine Khoury, PA | |
|
35 Park St, New Haven, CT 06519-1110 | |
| (203) 200-4716 | |
| Not Available |
| Full Name | Nesrine Khoury |
|---|---|
| Gender | Female |
| Speciality | Physician Assistant |
| Experience | 16 Years |
| Location | 35 Park St, New Haven, Connecticut |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023261203 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363A00000X | Physician Assistant | 5080 (Connecticut) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Yale-new Haven Hospital | New haven, CT | Hospital |
| Bridgeport Hospital | Bridgeport, CT | Hospital |
| Greenwich Hospital Association - | Greenwich, CT | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Yale University | 9436061736 | 2241 |
News Archive
Immunologists from Trinity College Dublin have unearthed a key piece of the MRSA vaccine puzzle by identifying specific ‘helper' cells whose role in the immune response is critical in affecting infection outcomes.
Democratic lawmakers will begin this week to try to hammer out a compromise between the House and Senate versions of a health care reform bill as they keep an eye on votes for the measures.
Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) today announced that it has submitted a supplemental new drug application (sNDA) to the U.S. Food and Drug Administration (FDA) requesting approval for the use of ENTEREG® (alvimopan) to accelerate GI recovery following any surgery that includes a bowel resection with primary anastomosis; expanded from the current indication in patients requiring surgery for colorectal disease.
Aimmune Therapeutics, Inc., a privately held biopharmaceutical company developing desensitization treatments for food allergies, announced today that a Phase 2 study (ARC001) evaluating the company's lead investigational product, AR101 for the treatment of peanut allergy, met its primary endpoint and additional endpoint of desensitizing patients to cumulative amounts of peanut protein of 443 mg and 1,043 mg, respectively.
Scientists have just discovered how the engine that powers cancer-killing cells functions. Crucially, their research also highlights how that engine is fuelled and that cholesterol-like molecules, called oxysterols, act as a "cut-off" switch making it hard for our 'Natural Killer' cells to win the war against cancer.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Nesrine Khoury, PA 35 Park St, New Haven, CT 06519-1110 Ph: () - | Nesrine Khoury, PA 35 Park St, New Haven, CT 06519-1110 Ph: (203) 200-4716 |
News Archive
Immunologists from Trinity College Dublin have unearthed a key piece of the MRSA vaccine puzzle by identifying specific ‘helper' cells whose role in the immune response is critical in affecting infection outcomes.
Democratic lawmakers will begin this week to try to hammer out a compromise between the House and Senate versions of a health care reform bill as they keep an eye on votes for the measures.
Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) today announced that it has submitted a supplemental new drug application (sNDA) to the U.S. Food and Drug Administration (FDA) requesting approval for the use of ENTEREG® (alvimopan) to accelerate GI recovery following any surgery that includes a bowel resection with primary anastomosis; expanded from the current indication in patients requiring surgery for colorectal disease.
Aimmune Therapeutics, Inc., a privately held biopharmaceutical company developing desensitization treatments for food allergies, announced today that a Phase 2 study (ARC001) evaluating the company's lead investigational product, AR101 for the treatment of peanut allergy, met its primary endpoint and additional endpoint of desensitizing patients to cumulative amounts of peanut protein of 443 mg and 1,043 mg, respectively.
Scientists have just discovered how the engine that powers cancer-killing cells functions. Crucially, their research also highlights how that engine is fuelled and that cholesterol-like molecules, called oxysterols, act as a "cut-off" switch making it hard for our 'Natural Killer' cells to win the war against cancer.
› Verified 5 days ago
Dr. Jennifer Anne Freimund, M.D. Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 1450 Chapel St Ste 107, New Haven, CT 06511 Phone: 310-663-6162 | |
Sydney M Judge, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 20 York St, New Haven, CT 06510 Phone: 203-688-4242 | |
Mr. Ryan Christian Rogers, PA-C Physician Assistant Medicare: Medicare Enrolled Practice Location: 20 York St, New Haven, CT 06510 Phone: 203-785-2618 Fax: 203-737-2221 | |
Mr. Matthew Ainey Gordon, PA-C Physician Assistant Medicare: Medicare Enrolled Practice Location: 20 York St, 3rd Floor West Pavilion, Cticu, New Haven, CT 06510 Phone: 203-785-2702 Fax: 203-785-3346 | |
Andrea Ferraro, Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 35 Park St Rm 209, New Haven, CT 06519 Phone: 203-284-0196 | |
Shelby Fundin, PA-C Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 20 York St, New Haven, CT 06510 Phone: 203-688-4242 | |
Rebecca A Bunnell, PA Physician Assistant Medicare: Medicare Enrolled Practice Location: 374 Grand Ave, Fair Haven Community Health Center, New Haven, CT 06513 Phone: 203-777-7411 Fax: 203-777-8506 |